In this month’s “Hot Topic,” Elitza Theel, Ph.D., talks about Mayo Clinic Laboratories’ serologic and molecular testing for the identification of infection with dengue virus. Dengue virus poses a significant public health threat worldwide. Rapid and accurate identification of the infection enables directed monitoring of patients who may be at increased risk of developing hemorrhagic fever of dengue shock syndrome.
A recent BuzzFeed article reported on 22-year-old Katie Stephens and her boyfriend, Eddie Zytner, a Canadian couple who recently went on a beach vacation in the Dominican Republic. During their vacation, they both developed cutaneous larva migrans, a skin infection caused by hookworms. Bobbi Pritt, M.D., Director of the Clinical Parasitology Lab and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Lab Medicine and Pathology, weighs in on the infection.